JIC
BIO icon

Joel Isaacson & Co’s Bio-Rad Laboratories Class A BIO Stock Holding History

Joel Isaacson & Co’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-5
Closed -$1K – 703
2014
Q4 		$1K Buy
+5
New +$575 ﹤0.01% 606

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Joel Isaacson & Co's BIO Position: Q1 2015 in Review

Joel Isaacson & Co sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2015, closing a stake of 5 shares — an estimated $1K sold.

Joel Isaacson & Co first reported a position in BIO in Q4 2014 and held it in 1 quarter. The position peaked at $1K in Q4 2014. 219 funds tracked by Wall St. Rank hold BIO as of Q1 2015.

  • Joel Isaacson & Co reported no remaining Bio-Rad Laboratories Class A position as of Q1 2015 after selling out during the quarter.
  • Joel Isaacson & Co sold 5 Bio-Rad Laboratories Class A shares in Q1 2015, an estimated $1K.
  • Joel Isaacson & Co first reported a position in Bio-Rad Laboratories Class A in Q4 2014 and held it in 1 quarter.
  • Joel Isaacson & Co's Bio-Rad Laboratories Class A position peaked at $1K in Q4 2014.
  • 219 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2015.

Based on Joel Isaacson & Co's 13F filing for Q1 2015, filed 14 Apr 2015.